Literature DB >> 10821423

Down regulation of myocardial beta1-adrenoceptor signal transduction system in pacing-induced failure in dogs with aortic stenosis-induced left ventricular hypertrophy.

J Tse1, M W Huang, R J Leone, H R Weiss, Y Q He, P M Scholz.   

Abstract

We recently demonstrated that rapid ventricular pacing caused cardiac failure (Failure) in dogs with aortic stenosis-induced left ventricular hypertrophy (Hypertrophy) and isoproterenol caused no significant increases in function, O2 consumption and intracellular cyclic AMP level in the failing hypertrophied hearts. We tested the hypothesis that alterations in the beta1-adrenoceptor-signal transduction pathway would correlate with the reduced functional and metabolic responses to beta-adrenergic stimulation during the transition from the compensated hypertrophy to failure. Pressure overload-induced left ventricular hypertrophy was created using aortic valve plication in 10 dogs over a 6-month period. Five months after aortic valve plication, congestive heart failure was induced in 5 dogs by rapid ventricular pacing at 240 bpm for 4 weeks. The density of myocardial beta1-adrenoceptors (fmoles/mg membrane protein; fmoles/g wet tissue) was significantly reduced in the Failure dogs (176+/-19; 755+/-136) when compared to those of the Control (344+/-51; 1,551+/-203) and the Hypertrophy (298+/-33; 1,721+/-162) dogs. The receptor affinities were not significantly different among all groups. There was a small but significant decrease in the percentage of beta1-adrenoceptors of the failing hypertrophied hearts (62+/-3%) when compared to that of the hypertrophied hearts (77+/-5%). The basal myocardial adenylyl cyclase activity (pmoles/mg protein/min) was significantly lower in the Failure dogs (45+/-4) than in the Control (116+/-14) and Hypertrophy (86+/-6) dogs. The forskolin (0.1 mM)-stimulated adenylyl cyclase activity was also significantly lower in the Failure dogs (158+/-17) than in the Control dogs (296+/-35) and slightly lower than in the Hypertrophy dogs (215+/-10). There were no significant differences in low Km cyclic AMP-phosphodiesterase activities among all groups. We conclude that down regulation of beta1-adrenoceptors and reduced adenylyl cyclase activities contribute to the decreases in myocardial functions and beta-adrenergic responses in the failing hypertrophied hearts induced by rapid ventricular pacing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821423     DOI: 10.1023/a:1007085027234

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of beta-adrenergic receptor, adenylate cyclase, and ventricular contraction.

Authors:  J Tse; J R Powell; C A Baste; R E Priest; J F Kuo
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

2.  Sarcoplasmic reticulum-associated cyclic adenosine 5'-monophosphate phosphodiesterase activity in normal and failing human hearts.

Authors:  M A Movsesian; C J Smith; J Krall; M R Bristow; V C Manganiello
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Alterations in activities of cyclic nucleotide systems and in beta-adrenergic receptor-mediated activation of cyclic AMP-dependent protein kinase during progression and regression of isoproterenol-induced cardiac hypertrophy.

Authors:  J Tse; N L Brackett; J F Kuo
Journal:  Biochim Biophys Acta       Date:  1978-09-06

4.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

5.  Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.

Authors:  M Böhm; B Pieske; P Schnabel; R Schwinger; B Kemkes; W P Klövekorn; E Erdmann
Journal:  J Cardiovasc Pharmacol       Date:  1989-10       Impact factor: 3.105

6.  Effects of pressure overload, left ventricular hypertrophy on beta-adrenergic receptors, and responsiveness to catecholamines.

Authors:  D E Vatner; C J Homcy; S P Sit; W T Manders; S F Vatner
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

7.  Chronic heart failure in the guinea pig increases cardiac alpha 1- and beta-adrenoceptors.

Authors:  J S Karliner; P Barnes; M Brown; C Dollery
Journal:  Eur J Pharmacol       Date:  1980-10-03       Impact factor: 4.432

8.  Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure.

Authors:  K Kiuchi; R P Shannon; K Komamura; D J Cohen; C Bianchi; C J Homcy; S F Vatner; D E Vatner
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

9.  Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects.

Authors:  J R Wilson; P Douglas; W F Hickey; V Lanoce; N Ferraro; A Muhammad; N Reichek
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

10.  Uncoupling between beta-adrenoceptors and adenylate cyclase in dog ischemic myocardium.

Authors:  C Devos; P Robberecht; P Nokin; M Waelbroeck; M Clinet; J C Camus; P Beaufort; P Schoenfeld; J Christophe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

View more
  2 in total

1.  Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals.

Authors:  Aniella Abi-Gerges; Wito Richter; Florence Lefebvre; Philippe Mateo; Audrey Varin; Christophe Heymes; Jane-Lise Samuel; Claire Lugnier; Marco Conti; Rodolphe Fischmeister; Grégoire Vandecasteele
Journal:  Circ Res       Date:  2009-09-10       Impact factor: 17.367

2.  Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy.

Authors:  Lexa Rae Turner; Daniel Aaron Premo; Brett Jason Gibbs; Megan Lesley Hearthway; Madelyne Motsko; Andrea Sappington; LeeAnn Walker; Michael Eugene Mullendore; Herbert George Chew
Journal:  BMC Physiol       Date:  2002-01-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.